<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(10)</volume><submitter>Keith JM</submitter><pubmed_abstract>A series of aryl piperazinyl ureas that act as covalent inhibitors of fatty acid amide hydrolase (FAAH) is described. A potent and selective (does not inhibit FAAH-2) member of this class, JNJ-40355003, was found to elevate the plasma levels of three fatty acid amides: anandamide, oleoyl ethanolamide, and palmitoyl ethanolamide, in the rat, dog, and cynomolgous monkey. The elevation of the levels of these lipids in the plasma of monkeys suggests that FAAH-2 may not play a significant role in regulating plasma levels of fatty acid ethanolamides in primates.</pubmed_abstract><journal>ACS medicinal chemistry letters</journal><pagination>823-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4025847</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.</pubmed_title><pmcid>PMC4025847</pmcid><pubmed_authors>Chang L</pubmed_authors><pubmed_authors>Wilson S</pubmed_authors><pubmed_authors>Wennerholm M</pubmed_authors><pubmed_authors>Scott B</pubmed_authors><pubmed_authors>Chaplan S</pubmed_authors><pubmed_authors>Pierce J</pubmed_authors><pubmed_authors>Xiao W</pubmed_authors><pubmed_authors>Webb M</pubmed_authors><pubmed_authors>Rizzolio M</pubmed_authors><pubmed_authors>Keith JM</pubmed_authors><pubmed_authors>Apodaca R</pubmed_authors><pubmed_authors>Seierstad M</pubmed_authors><pubmed_authors>Tichenor M</pubmed_authors><pubmed_authors>Luo L</pubmed_authors><pubmed_authors>Rynberg R</pubmed_authors><pubmed_authors>Breitenbucher JG</pubmed_authors><pubmed_authors>Jones W</pubmed_authors><pubmed_authors>Palmer J</pubmed_authors><pubmed_authors>Karbarz M</pubmed_authors><pubmed_authors>Brown S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.</name><description>A series of aryl piperazinyl ureas that act as covalent inhibitors of fatty acid amide hydrolase (FAAH) is described. A potent and selective (does not inhibit FAAH-2) member of this class, JNJ-40355003, was found to elevate the plasma levels of three fatty acid amides: anandamide, oleoyl ethanolamide, and palmitoyl ethanolamide, in the rat, dog, and cynomolgous monkey. The elevation of the levels of these lipids in the plasma of monkeys suggests that FAAH-2 may not play a significant role in regulating plasma levels of fatty acid ethanolamides in primates.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Oct</publication><modification>2025-04-04T08:41:59.252Z</modification><creation>2019-03-27T01:28:29Z</creation></dates><accession>S-EPMC4025847</accession><cross_references><pubmed>24900385</pubmed><doi>10.1021/ml300186g</doi></cross_references></HashMap>